"33342-362-57" National Drug Code (NDC)

Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate 180 TABLET in 1 BOTTLE (33342-362-57)
(Macleods Pharmaceuticals Limited)

NDC Code33342-362-57
Package Description180 TABLET in 1 BOTTLE (33342-362-57)
Product NDC33342-362
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameEfavirenz, Lamivudine And Tenofovir Disoproxil Fumarate
Non-Proprietary NameEfavirenz, Lamivudine And Tenofovir Disoproxil Fumarate
Dosage FormTABLET
UsageORAL
Start Marketing Date20190329
Marketing Category NameNDA
Application NumberNDA210649
ManufacturerMacleods Pharmaceuticals Limited
Substance NameEFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Strength400; 300; 300
Strength Unitmg/1; mg/1; mg/1
Pharmacy ClassesHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/33342-362-57